Clinical Trial Results:
A Randomised, Double-Blind, 52-Week, Parallel-Group, Multicentre, Phase IIb Study to Evaluate the Effects of Rosuvastatin 10 mg, Rosuvastatin 40 mg and Atorvastatin 80 mg on Urinary Protein Excretion in Hypercholesterolaemic Diabetic Patients with Moderate Proteinuria
PLANET I: Prospective evaLuation of proteinuriA and reNal function in diabETic patients with progressive renal disease
Summary
|
|
EudraCT number |
2005-002510-38 |
Trial protocol |
HU DK IT |
Global completion date |
01 Mar 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
09 Oct 2016
|
First version publication date |
09 Oct 2016
|
Other versions |
|
Summary report(s) |
D3569C00007 Protocol and Results Registration System (PRS) Receipt |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.